 random comparison intraven heparin oral aspirin dipyridamol hour recombin tissue-typ plasminogen activ acut myocardi infarct nation heart foundat australia coronari thrombolysi group background studi need heparin administr hour coronari thrombolysi recombin tissue-typ plasminogen activ rt-pa method result total patient acut myocardi infarct mg rt-pa bolu unit heparin units/hr i.v heparin hour hour patient intraven heparin therapi full dosag heparin therapi oral antiplatelet regimen aspirin mg/day dipyridamol mg/day prospect record differ pattern chest pain reinfarct complic coronari angiographi cardiac catheter day differ patenc infarct-rel arteri proport patient total occlus timi infarct-rel arteri heparin group aspirin dipyridamol group patient occlud infarct-rel arteri lumen normal heparin group aspirin dipyridamol group left ventricular function cardiac catheter radionuclid studi day month differ group left ventricular eject fraction radionuclid ventriculographi month heparin group aspirin dipyridamol group conclus heparin therapi hour rt-pa therapi oral antiplatelet regimen advers effect chest pain reinfarct coronari patenc ventricular function